This topic contains 0 replies, has 1 voice, and was last updated by  MS News Today Moderator 1 year, 4 months ago.

  • Author
    Posts
  • #12230
     MS News Today Moderator 
    Participant

    With the recent approval of Ocrevus (ocrelizumab) for both primary progressive and relapsing multiple sclerosis (MS), interest in the medication is peaking. To help readers of Multiple Sclerosis News Today better understand this new medication and how it works, as well issues dealing with access, use, and potential side effects, here is a summary of the most relevant information now available about Ocrevus.

    Click here to read more: What Every MS Patient Should Know About Ocrevus and Its Use

    Have you tried Ocrevus? Has it worked for you?

You must be logged in to reply to this topic.

Copyright © 2017-2019 All rights reserved.

©2019 KLEO Template a premium and multipurpose theme from Seventh Queen

CONTACT US

We're not around right now. But you can send us an email and we'll get back to you, asap.

Sending
or

Log in with your credentials

or    

Forgot your details?

or

Create Account